Literature DB >> 1383147

Differential effects of monoclonal antibodies to tumor necrosis factor alpha and gamma interferon on induction of hepatic nitric oxide synthase in experimental gram-negative sepsis.

T Evans1, A Carpenter, A Silva, J Cohen.   

Abstract

To investigate the stimuli required for the induction of nitric oxide synthase (NOS) in sepsis, we have analyzed the levels of this enzyme in the livers of mice infected with a 90% lethal dose of Escherichia coli in a model of gram-negative sepsis. Hepatic NOS levels are markedly induced in this model, with peak values occurring 12 to 22 h following infection. Treatment with TN3-19.12, a neutralizing monoclonal antibody to tumor necrosis factor alpha (TNF-alpha), resulted in complete protection from death in this model of sepsis but had no significant effect on the level of induction of hepatic NOS. Treatment with H22, a monoclonal antibody to gamma interferon (IFN-gamma), also gave significant protection against death and, in addition, did lead to a decrease in the level of induction of the hepatic NOS. Treatment of mice with pure TNF-alpha (0.2 microgram), IFN-gamma (2,000 U), or a combination of the two did not induce the hepatic NOS, but treatment with the combination led to significant mortality (probability of survival at 22 h, 0.32). Thus, the level of induction of NOS within the liver either in sepsis or by the coadministration of TNF-alpha and IFN-gamma does not correlate with death.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1383147      PMCID: PMC257445          DOI: 10.1128/iai.60.10.4133-4139.1992

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  36 in total

1.  Multiple cytokines are required to induce hepatocyte nitric oxide production and inhibit total protein synthesis.

Authors:  R D Curran; T R Billiar; D J Stuehr; J B Ochoa; B G Harbrecht; S G Flint; R L Simmons
Journal:  Ann Surg       Date:  1990-10       Impact factor: 12.969

2.  Inducible cytosolic enzyme activity for the production of nitrogen oxides from L-arginine in hepatocytes.

Authors:  T R Billiar; R D Curran; D J Stuehr; J Stadler; R L Simmons; S A Murray
Journal:  Biochem Biophys Res Commun       Date:  1990-05-16       Impact factor: 3.575

3.  Nitric oxide mediates glutamate-linked enhancement of cGMP levels in the cerebellum.

Authors:  D S Bredt; S H Snyder
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

4.  Monoclonal antibodies to murine gamma-interferon which differentially modulate macrophage activation and antiviral activity.

Authors:  R D Schreiber; L J Hicks; A Celada; N A Buchmeier; P W Gray
Journal:  J Immunol       Date:  1985-03       Impact factor: 5.422

5.  Generation and characterization of hamster monoclonal antibodies that neutralize murine tumor necrosis factors.

Authors:  K C Sheehan; N H Ruddle; R D Schreiber
Journal:  J Immunol       Date:  1989-06-01       Impact factor: 5.422

6.  Toxicity of tumor necrosis factor is synergistic with gamma-interferon and can be reduced with cyclooxygenase inhibitors.

Authors:  J E Talmadge; O Bowersox; H Tribble; S H Lee; H M Shepard; D Liggitt
Journal:  Am J Pathol       Date:  1987-09       Impact factor: 4.307

7.  Interleukin-1 receptor antagonist reduces mortality from endotoxin shock.

Authors:  K Ohlsson; P Björk; M Bergenfeldt; R Hageman; R C Thompson
Journal:  Nature       Date:  1990-12-06       Impact factor: 49.962

8.  NG-methyl-L-arginine inhibits tumor necrosis factor-induced hypotension: implications for the involvement of nitric oxide.

Authors:  R G Kilbourn; S S Gross; A Jubran; J Adams; O W Griffith; R Levi; R F Lodato
Journal:  Proc Natl Acad Sci U S A       Date:  1990-05       Impact factor: 11.205

9.  Prophylactic and therapeutic effects of a monoclonal antibody to tumor necrosis factor-alpha in experimental gram-negative shock.

Authors:  A T Silva; K F Bayston; J Cohen
Journal:  J Infect Dis       Date:  1990-08       Impact factor: 5.226

10.  An L-arginine-dependent mechanism mediates Kupffer cell inhibition of hepatocyte protein synthesis in vitro.

Authors:  T R Billiar; R D Curran; D J Stuehr; M A West; B G Bentz; R L Simmons
Journal:  J Exp Med       Date:  1989-04-01       Impact factor: 14.307

View more
  6 in total

1.  Gamma interferon prevents the inhibitory effects of oxidative stress on host responses to Escherichia coli infection.

Authors:  M J Parmely; F Wang; D Wright
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

2.  Gamma interferon production by hepatic NK T cells during Escherichia coli infection is resistant to the inhibitory effects of oxidative stress.

Authors:  Guochi Zhang; Robert Dru Nichols; Masaru Taniguchi; Toshinori Nakayama; Michael J Parmely
Journal:  Infect Immun       Date:  2003-05       Impact factor: 3.441

3.  Differential induction of nitric oxide synthase in various organs of the mouse during endotoxaemia: role of TNF-alpha and IL-1-beta.

Authors:  F Q Cunha; J Assreuy; D W Moss; D Rees; L M Leal; S Moncada; M Carrier; C A O'Donnell; F Y Liew
Journal:  Immunology       Date:  1994-02       Impact factor: 7.397

4.  The mechanism of the inhibitory effect of polyamines on the induction of nitric oxide synthase: role of aldehyde metabolites.

Authors:  C Szabó; G J Southan; C Thiemermann; J R Vane
Journal:  Br J Pharmacol       Date:  1994-11       Impact factor: 8.739

5.  Anti-tumor necrosis factor VNAR single domains reduce lethality and regulate underlying inflammatory response in a murine model of endotoxic shock.

Authors:  Rafael Bojalil; María Teresa Mata-González; Fausto Sánchez-Muñoz; Yepci Yee; Iván Argueta; Lucía Bolaños; Luis Manuel Amezcua-Guerra; Tanya Amanda Camacho-Villegas; Edna Sánchez-Castrejón; Walter Jakob García-Ubbelohde; Alexei Fedorovish Licea-Navarro; Ricardo Márquez-Velasco; Jorge Fernando Paniagua-Solís
Journal:  BMC Immunol       Date:  2013-04-02       Impact factor: 3.615

6.  Protective effect of 55- but not 75-kD soluble tumor necrosis factor receptor-immunoglobulin G fusion proteins in an animal model of gram-negative sepsis.

Authors:  T J Evans; D Moyes; A Carpenter; R Martin; H Loetscher; W Lesslauer; J Cohen
Journal:  J Exp Med       Date:  1994-12-01       Impact factor: 14.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.